SCHEMBL506645

SCHEMBL506645

CCOC(=O)C(C)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16377934 1.00
SCHEMBL12117545 0.80 ALDH1A1 (0.50)
SCHEMBL3137072 0.80 TSHR (0.33)
SCHEMBL5613231 0.80
SCHEMBL21811768 0.80 TSHR (0.31)
SCHEMBL2865612 0.80 ALDH1A1 (0.50)
SCHEMBL1009821 0.79 ALDH1A1 (0.43)
SCHEMBL5613628 0.79
SCHEMBL17899451 0.78
SCHEMBL10277489 0.77 PGR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115124570-B Preparation method of C3 phosphine salt 万华化学集团股份有限公司 2024-06-25 CN claimed
CN-114181097-B Synthesis method of methoxamine hydrochloride 广东嘉博制药有限公司 2024-05-14 CN claimed
CN-115124570-A Preparation method of C3 phosphonium salt 万华化学集团股份有限公司 2022-09-30 CN claimed
CN-114181097-A Synthetic method of methoxamine hydrochloride 广东嘉博制药有限公司 2022-03-15 CN claimed
CN-106220842-A The preparation method of poly glycol monomethyl ether propionic ester 江苏三宝邦佑生物科技有限公司 2016-12-14 CN claimed
US-20090306297-A1 PROCESS FOR PREPARING A COPOLYMER WITH CONTROLLED ARCHITECTURE, OF TELOMER OR BLOCK COPOLYMER TYPE, OBTAINED FROM VINYL PHOSPHONATE MONOMERS, BY IODINE TRANSFER POLYMERIZATION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-12-10 US claimed
EP-1976888-A1 PROCESS FOR PREPARING A COPOLYMER WITH CONTROLLED ARCHITECTURE, OF TELOMER OR BLOCK COPOLYMER TYPE, OBTAINED FROM VINYL PHOSPHONATE MONOMERS, BY IODINE TRANSFER POLYMERIZATION Rhodia Opérations (FR) 2008-10-08 EP claimed
WO-2007085623-A1 PROCESS FOR PREPARING A COPOLYMER WITH CONTROLLED ARCHITECTURE, OF TELOMER OR BLOCK COPOLYMER TYPE, OBTAINED FROM VINYL PHOSPHONATE MONOMERS, BY IODINE TRANSFER POLYMERIZATION RHODIA OPERATIONS (FR) 2007-08-02 WO claimed
US-6265499-B1 POLYMERIZING MIXTURE MENICON CO., LTD. (JP) 2001-07-24 US claimed
EP-0947527-A1 Waterborne block copolymers and process for making the same THE B.F. GOODRICH COMPANY (US) 1999-10-06 EP claimed
US-12534563-B2 Block copolymer, resin composition, stretch conductor, electronic device, and pressure-sensitive adhesive film ARTIENCE CO., LTD. (JP) 2026-01-27 US disclosed
EP-4406979-B1 COMPOUND AND PRODUCTION METHOD FOR COMPOUND DENKA COMPANY LTD (JP) 2025-11-12 EP disclosed
CN-120004901-A As WRN helicase inhibitors triazolo cyclic compounds 上海济煜医药科技有限公司 2025-05-16 CN disclosed
EP-3604352-B1 METHOD FOR PRODUCING A POLYMER USING A MOLECULAR-WEIGHT CONTROLLING AGENT FOR RADICAL POLYMERIZATION GODO SHIGEN CO LTD (JP) 2025-02-19 EP disclosed
US-20250011480-A1 CURABLE RESIN COMPOSITION KYOEISHA CHEMICAL CO., LTD. (JP) 2025-01-09 US disclosed
EP-0046291-B1 SUBSTITUTED CAPROLACTAM DERIVATIVES AS ANTIHYPERTENSIVES, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND INTERMEDIATES MERCK & CO. INC. (US) 1985-12-27 EP disclosed
EP-0049842-B1 SUBSTITUTED ENANTHOLACTAM DERIVATIVES, A PROCESS FOR THE PREPARATION AND A PHARMACEUTICAL COMPOSITION USEFUL IN THE TREATMENT OF HYPERTENSION COMPRISING THE SAME, AND INTERMEDIATES MERCK & CO. INC. (US) 1985-08-28 EP disclosed
US-4396616-A DIURETICS, ENZYME INHIBITORS MERCK & CO., INC. (US) 1983-08-02 US disclosed
EP-0049842-A2 Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates MERCK & CO. INC. (US) 1982-04-21 EP disclosed
EP-0046291-A2 Substituted caprolactam derivatives as antihypertensives, process for preparing them, pharmaceutical composition containing them, and intermediates MERCK & CO. INC. (US) 1982-02-24 EP disclosed